{"title":"硫硝嗪、三氟拉嗪、氯丙嗪和安慰剂的比较:治疗慢性住院精神分裂症患者的双盲对照研究。","authors":"B C SCHIELE, N D VESTRE, K E STEIN","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":86478,"journal":{"name":"Journal of clinical and experimental psychopathology & quarterly review of psychiatry and neurology","volume":" ","pages":"151-62"},"PeriodicalIF":0.0000,"publicationDate":"1961-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients.\",\"authors\":\"B C SCHIELE, N D VESTRE, K E STEIN\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":86478,\"journal\":{\"name\":\"Journal of clinical and experimental psychopathology & quarterly review of psychiatry and neurology\",\"volume\":\" \",\"pages\":\"151-62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1961-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical and experimental psychopathology & quarterly review of psychiatry and neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical and experimental psychopathology & quarterly review of psychiatry and neurology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients.